img
img
Serum Preptin as a Potential Biomarker for Metabolic Syndrome and Insulin Resistance    
Yazarlar (5)
Dr. Öğr. Üyesi Gamze TURNA SALTOĞLU Dr. Öğr. Üyesi Gamze TURNA SALTOĞLU
Kırşehir Ahi Evran Üniversitesi, Türkiye
Dr. Öğr. Üyesi Erkan DULKADİROĞLU Dr. Öğr. Üyesi Erkan DULKADİROĞLU
Kırşehir Ahi Evran Üniversitesi, Türkiye
Duygu Tozcu Yılmaz
Türkiye
Doç. Dr. Bilal İLANBEY Doç. Dr. Bilal İLANBEY
Kırşehir Ahi Evran Üniversitesi, Türkiye
Prof. Dr. Ülken Tunga BABAOĞLU Prof. Dr. Ülken Tunga BABAOĞLU
Kırşehir Ahi Evran Üniversitesi, Türkiye
Devamını Göster
Özet
Results:Serum preptin levels were significantly higher in MetS patients compared to the control group (53.77 pg/mL vs. 40.77 pg/mL, p< 0.001). MetS patients also had higher triglyceride, cholesterol, low-density lipoprotein cholesterol (LDL-C), fasting glucose, Hemoglobin A1c (HbA1c), insulin, and Homeostatic model assessment of insulin resistance (HOMA-IR) values compared to controls (all p< 0.001). A positive correlation was found between serum preptin, insulin (r= 0.432,% 95 CI: 0.07-0.57, p= 0.0050), and HOMA-IR (r= 0.426,% 95 CI: 0.08-0.56, p= 0.0060) in the MetS group.Conclusions:The results indicate that serum preptin levels are significantly elevated in MetS patients. Furthermore, high serum preptin levels were positively correlated with insulin and insulin resistance. These results suggest that preptin may be involved in the insulin resistance pathway via insulin-like growth factor II (IGF-II) modulation. Therefore, further extensive studies are required to fully understand the precise role in MetS and underlying mechanisms of preptin.
Anahtar Kelimeler
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Archives of Medical Science
Dergi ISSN 1734-1922 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q1
Makale Dili İngilizce
Basım Tarihi 01-2025
Doi Numarası 10.5114/aoms/209463
Makale Linki https://doi.org/10.5114/aoms/209463
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Serum Preptin as a Potential Biomarker for Metabolic Syndrome and Insulin Resistance

Paylaş